Comprehensive Market Analysis on Metabolomics Market projected to reach USD 5.0 Billion by 2030 | CAGR of 12.5% | Forecast period 2023-2030, published by MarketDigits

Metabolomics Market Scope:
Market size value in 2023 - USD 2.20 Billion
Market size value in 2030 - USD 5.0 Billion
CAGR (2023-2030) - 12.5%
Forecast Period - 2023-2030
Segments Covered - Product & Services, Application, Indication, End User & Region.
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Human Metabolome Technologies Inc., metaSysX, Metware Biotechnology Co.,Ltd., Thermo Fisher Scientific Inc., Analytik Jena GmbH, Biocrates life sciences AG.

Download Sample Pages-https://www.marketdigits.com/request/sample/1855

Browse in-depth TOC on "Metabolomics Market"
178-Tables
95-Figures
332-Pages

The market for Metabolomics is dominated by North America.
North America stands as the dominating region in the Metabolomics Market, with the United States and Canada playing pivotal roles in driving this market dominance. The region's leadership is attributed to robust research and development activities, substantial investments in healthcare, and a well-established healthcare infrastructure. In the United States alone, the National Institutes of Health (NIH) has been a key contributor, investing significantly in metabolomics research. Canada, with its strong focus on scientific research and healthcare excellence, also contributes significantly to the North American leadership in the metabolomics sector. The collaborative efforts between academic institutions, research organizations, and the pharmaceutical industry in both countries further amplify the region's influence. The continual growth in funding and research initiatives underscores North America's central role in advancing metabolomics technologies and applications on the global stage.

Ask for Discount- https://www.marketdigits.com/request/discount/1855

Top Key Players Covered in the Report-
Afekta Technologies Ltd., Agilent Technologies, Inc., Analytik Jena GmbH, BASF SE, BGI, Biocrates life sciences AG, Bruker, Creative Proteomics, DNA Xperts Private Limited, Human Metabolome Technologies Inc., LECO Corporation, Metabolomic Technologies Inc., Metabolon, Inc., metaSysX, Metware Biotechnology Co.,Ltd., MS-OMICS, PerkinElmer Inc., SCIEX (Danaher), Shimadzu Corporation, Thermo Fisher Scientific Inc., Vproteomics, Waters Corporation and Others.

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/1855

Recent Developments
In July 2021, Thermo Fisher Scientific along with the University of California launched a research collaboration, to provide innovations, standard operating procedures, and best practices to the metabolomics community. These initiatives are sure to provide robust market growth opportunities in the future.

https://industrytoday.co.uk/market-research-industry-today/emerging-trends-and-innovations-for-the-metabolomics-market-projected-to-reach-usd-50-billion-by-2030#google_vignette

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.